Improving cancer care for underserved patients using a new health platform
Official title: Bridging the Gap: Enhancing Cancer Care for Underserved Populations with the Veris Health Cancer Care Platform
Funded at Pavmed INC. · NIH-10919645 · Data updated 2026-11-12
This study is working to make a helpful online tool for cancer patients who might not have easy access to care, especially those facing language or tech challenges, so they can better connect with their doctors while getting chemotherapy and improve their overall treatment experience.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pavmed INC. NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 22, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $892,112 |
| NIH project number | 1R44MD019611-01 |
| Project ID | NIH-10919645 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are medically underserved cancer patients receiving outpatient chemotherapy, particularly those with language barriers or limited access to technology.
✕Less likely to help
Patients who are not receiving outpatient chemotherapy or those who have adequate access to healthcare resources may not benefit from this research.
What this research studies
This research aims to enhance the Veris Health Cancer Care Platform to better serve medically underserved cancer patients undergoing outpatient chemotherapy. The platform is designed for remote patient monitoring and communication, helping oncology teams gather important data between clinical visits. The study focuses on making the platform user-friendly for patients facing language barriers and technological challenges, ensuring it is culturally appropriate and accessible. By collaborating with community health centers, the research will validate the platform's effectiveness through both quantitative data and patient interviews, aiming to reduce hospital visits and improve overall cancer care outcomes.
Why it matters
Potential benefit: If successful, this research could significantly improve cancer care for underserved populations, leading to better health outcomes and reduced healthcare costs.
How similar studies have gone: Previous research has shown success in using remote monitoring platforms to improve patient outcomes, indicating a promising approach for this study.
Where this research is happening
-
Pavmed INC.
New York, United States Active
Researchers
- Principal investigator: Mitchell, James — Pavmed INC.
- Study coordinator: Mitchell, James
Related research
Other NIH-funded projects on the same topics.
-
Veris Health remote support to help underserved cancer patients during chemotherapy
Using a phone- and web-based monitoring and communication tool to support underserved patients getting outpatient chemotherapy, especially those with language or technology barriers.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.